Plakous Therapeutics Announces New Funding To Support Development Of Therapies For Necrotizing Enterocolitis
Jul 05, 2022•over 3 years ago
Description
Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina Biotechnology Center (NCBiotech). The funding will support ongoing development and marketing of Protego-PDTM, the regenerative medicine company's first product.